Hospital Chargemasters Leading to Confused Patients, Questions About Costs

A new federal law praised for what some considered a giant leap toward increased healthcare transparency may be making an already-confusing experience even more confusing. The rule effective Jan. 1 requires hospitals to publicize prices online for any services they offer. Unfortunately for patients, early reports on the process have not been favorable.

Read more

Generic Insulin Could Lower Costs, but Red Tape and Prescribing Habits Won’t Make It Easy

Imagine you spend years fine-tuning formulas and undergoing tests, trials, and experiments, before finally developing a potentially life-saving drug. And then two of your neighbors do the same. Over the next century or so, the three of you control the overwhelming majority of the market for that drug, raising prices as you wish and leaving little room for competition or a generic alternative.

Read more

Big Pharma Balks at Lowering Own Prices in Response to Rising Drug Costs

Leadership from seven different drug makers appeared before the Senate Finance Committee late last month , to provide their recommendations for solving the crisis surrounding drug costs. The executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer, and Sanofi presented an assortment of ideas that were heavy on finger-pointing and light on actionable solutions.

Read more


connect

Sign in with Facebook, Twitter or email.